CoChat

Apolipoprotein A‐IV, a Putative Satiety/Antiatherogenic Factor, Rises After Gastric Bypass

Open access
Culnan, Derek M., Cooney, Robert N., Stanley, Bruce, Lynch, Christopher J. · 2009 · Obesity
Cited by 62

The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.

Abstract

Roux‐en‐Y gastric bypass surgery (RYGBP) leads to improvements in satiety and obesity‐related comorbidities. The mechanism(s) underlying these improvements are not known but may be revealed in part by discovery proteomics. Therefore, fasting plasma was collected from 12 subjects (mean BMI >45) during RYGBP and during a second procedure ∼17 months later. Body weight, obesity‐related comorbidities, and medication use were decreased after RYGBP. Mass spectrometry‐based proteomic analysis was performed on a subset of seven samples using isobaric isotope‐coded affinity tags (four plex iTRAQ). Initial proteomic analysis (n = 7) quantified and identified hundreds of plasma proteins. Manual inspection of the data revealed a 2.6 ± 0.5‐fold increase in apolipoprotein A‐IV (apo A‐IV, gene designation: APOA4), a ∼46‐kDa glycoprotein synthesized mainly in the bypassed small bowel and liver after RYGBP. The change in apo A‐IV was significantly greater than other apolipoproteins. Immunoblot analysis of the full longitudinal sample set (n = 12) indicated even higher increases (8.3 ± 0.2 fold) in apo A‐IV. Thus iTRAQ may underestimate the changes in protein concentrations compared to western blotting of apo A‐IV. Apo A‐IV inhibits gastric emptying and serves as a satiety factor whose synthesis and secretion are increased by the ingestion of dietary fat. It also possesses anti‐inflammatory and antiatherogenic properties. Based on these functions, we speculate changes in apo A‐IV may contribute to weight loss as well as the improvements in inflammation and cardiovascular disease after RYGBP. In addition, the findings provide evidence validating the use of iTRAQ proteomics in discovery‐based studies of post‐RYGBP improvements in obesity‐related medical comorbidities.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/oby.2008.428

Cites

5 of 5 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 5 references

Cited by

See all 62

Metadata

Authors
Culnan, D. M., Cooney, R. N., Stanley, B., & Lynch, C. J.
Venue
Obesity
Publisher
Wiley
Published
2009-01
Volume
17
Issue
1
Pages
46-52
ISSN
  • 1930-7381 (ISSN-L)
  • 1930-739X
OpenAlex
W2084098671
Cited by
62
References
5
FWCI
4.53
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Apolipoprotein A‐IV, a Putative Satiety/Antiatherogenic Factor, Rises After Gastric Bypass. https://app.cochat.ai/papers/10.1038/oby.2008.428
The paper
Culnan, D. M., Cooney, R. N., Stanley, B., & Lynch, C. J. (2009). Apolipoprotein A‐IV, a Putative Satiety/Antiatherogenic Factor, Rises After Gastric Bypass. Obesity. https://doi.org/10.1038/oby.2008.428

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.